Currently, there are 153.43M common shares owned by the public and among those 94.65M shares have been available to trade.
The company’s stock has a 5-day price change of -5.60% and 26.42% over the past three months. ZS shares are trading -10.34% year to date (YTD), with the 12-month market performance up to 0.31% higher. It has a 12-month low price of $153.45 and touched a high of $259.61 over the same period. ZS has an average intraday trading volume of 1.91 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.31%, 4.18%, and 6.06% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Zscaler Inc (NASDAQ: ZS) shares accounts for 48.81% of the company’s 153.43M shares outstanding.
It has a market capitalization of $30.48B and a beta (3y monthly) value of 0.83. The earnings-per-share (ttm) stands at -$0.24. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.89% over the week and 3.09% over the month.
Earnings per share for the fiscal year are expected to decrease by -6.41%, and 19.09% over the next financial year. EPS should grow at an annualized rate of 18.50% over the next five years, compared to -10.72% over the past 5-year period.
Looking at the support for the ZS, a number of firms have released research notes about the stock. BMO Capital Markets stated their Outperform rating for the stock in a research note on Dec-04-24, with the firm’s price target at $197-$222. Exane BNP Paribas coverage for the Zscaler Inc (ZS) stock in a research note released on October 08, 2024 offered a Neutral rating with a price target of $180. BMO Capital Markets was of a view on September 04, 2024 that the stock is Outperform, while BofA Securities gave the stock Neutral rating on September 04, 2024, issuing a price target of $195. Raymond James on their part issued Mkt Perform rating on July 23, 2024.
